BioTech and Pharma Startups, Investors & Professionals Networking Event

🔔 **Please Note:** RSVP on Meetup **does not guarantee entry**. To attend, you **must register through the official ticket link** here: [https://www.eventbrite.com/e/1983367109415?aff=oddtdtcreator](https://www.eventbrite.com/e/1983367109415?aff=oddtdtcreator) Come meet Biotech startups, investors, and innovators! Network, collaborate, and grow with like-minded professionals and industry leaders. Join us for an exclusive **Biotech & Pharma Networking Event**, bringing together **startup founders, investors, researchers, and industry professionals** shaping the future of pharmaceuticals and biotech. Whether you're developing **new drug therapies, AI-driven healthcare solutions, or innovative pharmaceutical technologies**, this event is designed to foster **strategic connections, investment opportunities, and industry collaboration**. **What to expect:** **High-Impact Networking** – Engage with **pharma founders, investors, and professionals** in a collaborative setting. **1-Minute Elevator Pitches** – Startups will have the chance to **introduce their business, highlight their innovation, and connect with investors and partners**. **Investment & Funding Opportunities** – Meet investors seeking **high-growth pharma startups and breakthrough medical innovations**. **Industry Insights & Market Trends** – Discuss advancements in **drug development, AI in pharma, regulatory changes, biotech innovations, and more**. **Strategic Partnerships** – Find **research collaborators, regulatory advisors, and commercialization experts**to help scale your venture. **Who should attend?** * **Pharma & Biotech Startup Founders** – Entrepreneurs developing **new therapeutics, AI-driven pharma solutions, or innovative drug delivery technologies**. * **Investors & Venture Capitalists** – Seeking **disruptive startups and groundbreaking innovations in pharmaceuticals and life sciences**. * **Pharmaceutical Industry Professionals** – Engaging with **startups, researchers, and investors*